In addition, IHC analysis of tumor xenografts revealed coordinated dysregulation of key biomarkers in HSPD1-knockdown tumors: HSP60, HK2, and Ki67 expression were significantly reduced, while p53 levels increased (Fig. 5L). The gene discussed is HSPD1; the disease is neoplasm.